Table 1 Demographic and clinical characteristics of patients.

From: Relationship between subjective well-being and aripiprazole: an [11C]raclopride PET study

Demographic characteristics

Age (years)

32.1

(9.7)

Female gender (n)

6

(75.0)

Height (cm)

162.8

(10.4)

Weight (kg)

63.2

(16.3)

Clinical characteristics

Aripiprazole dose (mg)

13.1

(11.6)

Duration of maintenance dose (month)

25.1

(27.2)

PANSS score

 Total

42.5

(8.9)

 Positive symptoms

8.0

(1.1)

 Negative symptoms

12.8

(4.9)

 General symptoms

21.9

(3.8)

Kv-SWN score

93.0

(15.0)

SAS score

1.1

(0.9)

AIMS score

0.4

(0.7)

BARS score

0.7

(1.2)

  1. All variables are presented as mean (± SD), or n (%).
  2. PANSS Positive and Negative Syndrome Scale, Kv-SWN Korean version of Subjective Well-Being under Neuroleptics Scale-Short form, SAS Simpson–Angus Scale, AIMS Abnormal Involuntary Movement Scale, BARS Barnes Akathisia Rating Scale.
Back to article page